University of Southern California

Research

RFA-RM-18-006: Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 – Clinical Trial Not Allowed)

Slots:                                                     2                             

Internal Deadline:                           May 4th, 2018 noon

LOI:                                                        30 days prior to the application due date              

External Deadline:                          June 11, 2018, by 5:00 PM local time

Award Information:                        Type:  Cooperative Agreement

Estimated Number of Awards: 10

Anticipated Amount: maximum total of $40,000,000 total costs in FY2019

Submission Process:                     PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://app.wizehive.com/webform/USCgrants

Materials to submit:

Link to Award:                                  https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-18-006.html

Who May Serve as PI:                    Participants in the Research Enrichment Core:

It is expected that eligibility for BUILD II supported activities will be open to participants at Participating and Partner Institutions, who are, or plan to be, biomedically-related STEM majors. The applicant institution is responsible for selecting participants who will receive BUILD II RL5 financial support. Participants supported through a RL5-linked award must be U.S. citizens or non-citizen nationals or permanent residents and must be enrolled full time at the applicant institution or Pipeline Partner or Graduate Partner institution (if applicable).  A non-citizen national is a person who, although not a citizen of the United States, owes permanent allegiance to the U.S. This is generally a person born in a land that is not a state, but that is under U.S. sovereignty, jurisdiction, or administration, e.g., American Samoa. An individual lawfully admitted for permanent residence must possess a currently valid Permanent Resident Card (USCIS Form I-551) or other legal verification of such status prior to receiving financial benefit from or employment on the grant. Individuals on temporary visas, those seeking asylum, or refugees are not eligible for support from this program. A limited range of enrichment activities, including research training and participation in research projects, may be offered to high school seniors who are concurrently enrolled in college bridge programs for biomedical sciences at participating institutions, but such students are not eligible to receive financial support from BUILD awards.

Trainees in the Training Core:

It is expected that eligibility for BUILD II-supported activities will be open to all trainees at Participating Institutions who are, or plan to be, biomedically-related majors. The applicant institution is responsible for selecting trainees who will receive BUILD II TL4 financial support. Student trainees supported through a TL4-linked training award must be at the undergraduate level, U.S. citizens or non-citizen nationals or permanent residents, and must be enrolled full time in academic degree programs in biomedical science fields at the applicant institution. A non-citizen national is a person who, although not a citizen of the United States, owes permanent allegiance to the U.S. This is generally a person born in a land that is not a state, but that is under U.S. sovereignty, jurisdiction, or administration, e.g., American Samoa. An individual lawfully admitted for permanent residence must possess a currently valid Permanent Resident Card (USCIS Form I-551) or other legal verification of such status prior to receiving financial benefit from or employment on the grant. Individuals on temporary visas, those seeking asylum, or refugees are not eligible for support from this program.

Purpose:

This Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the current Building Infrastructure Leading to Diversity (BUILD) awards. BUILD is part of the Enhancing the Diversity of the NIH-Funded Workforce Program, also known as the Diversity Program Consortium (DPC). The DPC consists of three integrated initiatives: BUILD, the National Research Mentoring Network (NRMN) and the Coordination and Evaluation Center (CEC). The purpose of the funding opportunity is to allow BUILD sites to continue to implement and evaluate the multi-pronged student, faculty, and institutional interventions to enhance diversity in the NIH biomedical research workforce. In preparation for the second phase of the BUILD initiative, the applicants are expected to provide plans to transition into sustainable models for enhancing diversity in the biomedical research fields at their institutions. Applicants are also expected to develop an effective training, mentoring, or research capacity building intervention that will be disseminated to other institutions to increase the national impact of the initiative.

The first phase of the program provided an opportunity to establish the types of interventions and evaluative frameworks needed to begin understanding and addressing multi-dimensional factors that strongly influence success. The DPC implemented interventions and evaluative practices designed to understand effective approaches to mentoring, student engagement, research capacity building, faculty development, and infrastructure development. The interventions were designed around the following questions:

The second, and final, phase of this program, will allow the DPC to continue gathering data required to address the questions listed above and to assess the longer-term outcomes. During this phase, grantees are expected to refine their approaches and evaluations and to focus on sustainability and dissemination of successful interventions. Additional relevant questions for the final phase include, but are not limited to:

The program consists of three highly integrated initiatives, in which awardees work together as the Diversity Program Consortium described below.

Visit our Institutionally Limited Submission webpage for updates and other announcements.